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The Splicing Factor BBP Interacts
Specifically with the Pre-mRNA Branchpoint
Sequence UACUAAC
J. Andrew Berglund,* Katrin Chua,² bridge the 39 and 59 splice-site ends of the intron during
the early steps of yeast pre-mRNA splicing (AbovichNadja Abovich,* Robin Reed,²
and Michael Rosbash*³ and Rosbash, 1997).
BBP, as well as its mammalian ortholog, SF1, contains*Howard Hughes Medical Institute
Department of Biology and Biochemistry RNA-binding motifs, and SF1 has been shown to pos-
sess general RNA-binding properties in vitro (Arning etBrandeis University
Waltham, Massachusetts 02254 al., 1996; Abovich and Rosbash, 1997). Based on pri-
mary sequence conservation (Arning et al., 1996; Abo-²Department of Cell Biology
Harvard Medical School vich and Rosbash, 1997), the similar functional proper-
ties of BBP and SF1 (Abovich and Rosbash, 1997; thisBoston, Massachusetts 02115
work), and the fact that two different splicing activities
named SF1 have been reported (Krainer and Maniatis,Summary
1985; Kramer, 1992), we refer to SF1 (Kramer, 1992) as
mBBP.The yeast splicing factor BBP (branchpoint bridging
Here, we show that BBP UV cross-links to pre-mRNAprotein) interacts directly with pre-mRNA at or very
at or very near the pre-mRNA branchpoint sequencenear the highly conserved branchpoint sequence
during commitment-complex assembly. We made a re-UACUAAC within the commitment complex. We also
combinant form of BBP and tested its in vitro RNA-show that the recombinant protein recognizes the
binding properties with small synthetic RNA substrates.UACUAAC sequence. Therefore, BBP is also an acro-
Remarkably, BBP has striking sequence specificity fornym for branchpoint binding protein. The mammalian
the branchpoint sequence, indicating that its interactionsplicing factor SF1 is a BBP ortholog (mBBP) and an
with the branchpoint region is not solely dependent onE complex component, and also has branchpoint se-
protein±protein interactions. Recombinant mBBP alsoquence specificity. The relative conservation of this
recognizes the UACUAAC sequence but with less speci-region in yeast and mammals correlates well with the
ficity than that of BBP. This parallels the differences inRNA-binding differences between BBP and mBBP,
branchpoint-sequence conservation between yeast andsuggesting that BBP contributes to branchpoint se-
quence definition in both systems. mammals, suggesting that the earliest definition of the
branchpoint region in both systems involves a specific
Introduction interaction between BBP and the pre-mRNA branch-
point sequence during commitment-complex formation.
The branchpoint sequence is conserved in both yeast
and mammalian pre-mRNAs. In yeast (S. cerevisiae), this
sequence is UACUAAC and almost invariant. In contrast, Results
in mammals the branchpoint sequence is degenerate,
with a consensus sequence of YNCURAY (Y 5 pyrimi- We first used UV cross-linking to address a possible
dine; R 5 purine; N 5 any nucleotide) (Moore et al., direct association between BBP and pre-mRNA within
1993). The 2'-OH of the underlined adenosines forms commitment complexes. RNase T1 digestion and spe-
the lariat intermediate during the first step of splicing. cific immunoprecipitation of a radioactive BBP±HA-
In addition to participating in the chemistry of splicing, tagged protein indicates close contact between BBP
thebranchpoint sequence is important for splicing-com- and radioactive pre-mRNA (Figure 1A). The absence of
plex formation (Pikielny et al., 1986; Champion-Arnaud signal from a nontagged extract (Figure 1A, lane 1) veri-
et al., 1995; Chiara et al., 1996; Query et al., 1996). This fied the specificity of the immunoprecipitation. Impor-
is due in part to a base-pairing interaction between this tantly, BBP did not cross-link to a pre-mRNA substrate
sequence and a highly conserved region of U2 snRNA with a deletion of its UACUAAC sequence (Figure 1A,
(Parker et al., 1987; Wu and Manley, 1989; Zhuang and lanes 3 and 4).
Weiner, 1989). The yeast branchpoint region is also nec- To determine whether BBP contacts pre-mRNA in the
essary for an earlier step of splicing, i.e., commitment- vicinity of the branchpoint sequence, we generated
complex formation. The commitment complex is the a nearly wild-type pre-mRNA substrate that was 32P-
substrate for U2 snRNP addition and contains pre- labeled at a single position 3 nt downstream of the
mRNA, U1 snRNP, the protein Mud2p, and other uniden- UACUAAC sequence (Figure 1B). Digestion with RNase
tified protein factors (Abovich et al., 1994). One of these T1 prior to gel electrophoresis indicates that the site of
proteins, BBP (branchpoint bridging protein), was re- the protein±RNA cross-link is at or very close to the
cently identified in a Mud2p-dependent synthetic lethal branchpoint sequence (Figures 1B and 1C). This is sup-
screen (Abovich and Rosbash, 1997). Genetic and bio- ported by a significant reduction in signal with RNase
chemical evidence showed that BBP interacts with A digestion (data not shown), which further delimits the
Mud2p and the yeast U1 snRNP protein PRP40p. There- cross-link site to the branchpoint region. Since these
fore, BBP is involved in protein±protein interactions that experiments were done under commitment-complex
conditions (no ATP and/or oligonucleotide-mediated
RNase H digestion of U2 snRNA), they suggest a simple³To whom correspondence should be addressed.
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Figure 2. Schematic Representation of mBBP and BBP
The KH domain and Zn knuckle domains are boxed. The arrows
represent the start and end sites of the recombinant proteins
BBP(193) and mBBP(181).
To test the possibility of specific binding to the
UACUAAC sequence, the putative RNA-binding regions
of both proteins were purified after expression in E. coli
(see Experimental Procedures). For BBP, the expressed
region consists of amino acids 145±330 plus a 6His-tag
at the N-terminus, i.e., 193 amino acids and an approxi-
mate molecular mass of 22 kDa. For mBBP, it is from
amino acids 134±307, i.e., the same predicted molecular
massof 22kDa (data not shown). To distinguish between
Figure 1. UV Cross-Linking of BBP to Pre-mRNA in Commitment
the full-length natural proteins and these two recombi-Complexes
nant fragments, we have named the latter BBP(193) and(A) Commitment complexes assembled with the indicated extracts
mBBP(181). The same purification scheme was used forand uniformly labeled wild type (lanes 1 and 2), or a 7 bp deletion
both recombinant proteins: Ni-NTA agarose (Qiagen)of the UACUAAC sequence (lanes 3 and 4), were UV irradiated. After
RNase T1 digestion and immunoprecipitation with 12CA5 antibody, followed by a CM±Sepharose column. The second col-
the radiolabeled proteins were separated on an 8% acrylamide±SDS umn increased purity to approximately 90% and elimi-
gel. nated contaminating RNA binding and ribonuclease ac-
(B) Sequence of the pre-mRNA in the branchpoint region used in
tivities; both purified proteins have the same apparentthe site specific cross-linking experiment with the branchpoint se-
molecular mass of 22 kDa (data not shown). At this point,quence underlined. The asterisk represents the radiolabeled guano-
the proteins were used for gel-shift and filter-bindingsine. The lower case guanosine was changed from a uridine for
transcriptional reasons. The large arrows above the sequence repre- assays. The wild-type RNA substrate was a 22 nt oligo-
sent RNase T1 cleavage sites, and the small arrows represent RNase nucleotide containing the natural branchpoint sequence
A cleavage sites. plus surrounding sequence from the yeast rp51A intron
(C) Same as in (A) except that the substrate (wild-type pre-mRNA)
(Teem and Rosbash, 1983) (Table 1).contained a single labeled phosphate, such that after T1 digestion,
BBP(193) interacts with the oligonucleotide, and thea 12 nt fragment containing the UACUAAC sequence is radiolabeled.
apparent KD is 500 nM (Figure 3A; Table 1). We tested
for specific binding by using mutant versions of the 22explanation for the UACUAACrequirement for BBP±pre-
nt sequence. The gel-shift assay demonstrated that allmRNA contact (Figure 1A): BBP interacts directly with
mutants within the UACUAAC sequence had a negativethe branchpoint sequence during the earliest steps of
effect on the apparent KD (Figure 3; Table 1). Alterationsplicing-complex formation.
of the branchpoint adenosine (to all three other possibili-BBP interacts with the splicing factor Mud2p and with
ties) or the adjacent uridine (the fourth position withinthe U1 snRNP protein PRP40p (Abovich and Rosbash,
UACUAAC) eliminated detectable BBP(193) binding (Ta-1997), and we suspected that these protein±protein in-
ble 1 [2]). The other five point mutants within thebranch-teractions serve to position BBP at or near the branch-
point sequence reduced binding approximately 5- to 20-point sequence. Branchpoint binding and branchpoint
fold compared to the wild-type sequence (Table 1 [1]).recognition would then be dependent on these interac-
All mutations outside the UACUAAC sequence weretions. However, we considered the possibility that BBP
without effect (Table 1 [11]).and even its mammalian ortholog, mBBP, might have
Because an interaction with RNAs mutant at thesome specificity for the UACUAAC sequence. BBP con-
branchpoint adenosine or at the adjacent uridine wastains three RNA-binding motifs: a KH domain (Siomi et
too weak to detect with the gel-shift assay, competitional., 1993; Musco et al., 1996) and two retroviral Zn
experiments were undertaken to estimate the KD of bind-knuckle domains (Darlix et al., 1995); its mammalian
ing to these mutant substrates. Nonradioactive wild typeortholog, mBBP, has a KH domain and a single Zn
or mutant RNA was used to compete binding to radioac-knuckle domain (Figure 2) (Arning et al., 1996; Abovich
tive wild-type RNA (Figure 3B).and Rosbash, 1997). The two proteins share extensive
For all three branchpoint mutations, a 125-fold excesssequence similarity, and mBBP has been shown to pos-
of nonradioactive mutant RNA was necessary to ob-sess general RNA-binding properties (Arning et al.,
1996). serve comparable competition to that observed with
BBP Recognizes the Branchpoint Sequence
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Table 1. Summary of Binding Data for BBP(193) and mBBP(181)
The arrow marks the position of the branchpoint adenosine. Two
plus signs (11) indicate wild-type binding with an approximate KD
of 500 nM for BBP(193) and 30 mM for mBBP(181). One plus sign
(1) indicates a decrease of approximately of 5- to 20-fold in binding
Figure 3. Gel Shift with BBP(193) as assayed by gel shift. The minus sign (2) indicates no binding by
gel shift for BBP(193). In the case of mBBP(181), the minus sign (2)(A) Direct assay with four different oligonucleotides, as marked be-
indicates little or no binding by gel shift.low each panel. The top left is wild type, and the other three are
mutants within the UACUAAC sequence. Mutations are in bold and
underlined. The range of BBP(193) concentration is from 230 nmol
to 9 mmol.
T2 digestion by BBP(190) (Figure 4A). Taken together(B) Competition experiment using radiolabeled wild-type branch-
point oligo and a constant amount of BBP(193), 2 mmol. Cold oligo with the binding data (Table 1), the additional nucleo-
was added in excess as labeled above the figure, and the mutant tides probably indicate nonspecific (e.g., backbone)
shown here is the branchpoint (lariat forming) adenosine changed binding to these positions or steric inhibition of RNase
to a cytidine. These experiments were repeated multiple times with
T2 digestion.different protein preparations, yielding the same results.
The mammalian branchpoint consensus is degener-
ate, but the highly conserved yeast sequence UACUAAC
wild-type RNA. This indicates that a single nucleotide
is also the optimal branchpoint sequence for mammals
change at the branchpoint adenosine (to C, U, or G)
(Zhuang et al., 1989; Moore et al., 1993). Taken together
decreases the binding affinity of BBP(193) by at least
with the extensive conservation between mBBP and100-fold (Figure 3B). Mutations at position 4 were less
BBP (Arning et al., 1996), we considered that mBBPdramatic, as only a 25-fold excess of mutant RNA
might also manifest similar sequence-specific binding.matched the competition profile of wild-type RNA (data
We therefore assayed binding of mBBP(181) to the samenot shown). Mutations at other branchpoint positions
wild type and mutant RNA oligonucleotides (Figure 5).were also examined in this way, and they were 5- to
mBBP(181) binds to the wild-type oligonucleotide with20-fold less efficient than wild-type RNA (data not
a KD of 30 mM, about 50-fold weaker than BBP(193).shown). These competition results support those ob-
However, mBBP(181) still manifested substantial speci-tained in the direct assay (Table 1). Both approaches
ficity for the branchpoint sequence: like BBP(193), muta-indicate that the branchpoint adenosine and adjacent
tions at the branchpoint adenosine and the upstreamuridine are most important for specificity. Mutations at
uridine had the strongest effects on mBBP(181) binding.all other branchpoint locations have detectable but less
In contrast to BBP(193), however, these were the onlysevere effects.
two positions to affect mBBP(181) binding (Table 1). TheTo verify the direct interaction between BBP and the
gel-shift assay indicated that mutating the upstreamUACUAAC branchpoint sequence, we also used a foot-
uridine reduced binding 10-fold compared to the wild-printing assay (Figure 4A). For this experiment, we used
type sequence (Figure 5A). Because binding to theBBP(190) (see Experimental Procedures) and a larger
branchpoint adenosine mutants could not be detectedsubstrate containing 35 nt from the rp51A intron branch-
by gel-shift, we used competition experiments to esti-point region (Figure 4B). The RNA was end labeled and
mate the difference in affinity between wild-type RNAdigested with RNase T1 or T2 in the presence or absence
and the branchpoint adenosine mutants (Figure 5B). Forof BBP(190). As predicted, there is a strong footprint
all three mutants, the binding constant was reducedover the UACUAAC branchpoint sequence; only two ad-
ditional nucleotides on either side are protected from approximately 25-fold (Figure 5B; Table 1). This more
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Figure 4. Footprint of BBP(190) on a 35 nt RNA Containing the
Branchpoint Sequence
Figure 5. Gel Shift with mBBP(181)(A) The T1 cleavage sites allowed a precise determination of the
branchpoint-sequence nucleotides. Only with RNase T2, in the pres- (A) Direct assay with four different oligonucleotides. The wild-type
ence of BBP(190) (lanes 6 and 7), is protection of the branchpoint sequence (top left), and the oligo with a mutation outside of the
sequence observed. There is also protection of two nucleotides to branchpoint (lower left), both bind mBBP(181) with similar affinity.
either side of the branchpoint sequence. While the mutations in the branchpoint (top right and lower right)
(B) The sequence of the 35 nt RNA, with the branchpoint sequence show no or very little binding, mBBP(181) concentrations range from
in larger case, bold, and underlined. 4±65 mmol. These experiments were repeated multiple times with
different protein preparations, yielding the same results.
(B) Competition experiment using radiolabeled wild-type branch-
point oligo and a constant amount of mBBP(181), 30 mmol. Coldlimited specificity probably reflects the relative evolu-
oligo was added in excess as labeled above the figure, and thetionary constraints on mammalian and yeast branch-
mutant shown here is the branchpoint (lariat forming) adenosine
point sequences (see Discussion). changed to a cytidine.
Discussion
the branchpoint sequence in a similar manner. This is
also based on the primary sequence conservation be-Using purified recombinant forms of yeast BBP and
mammalian mBBP, we show that both proteins interact tween mBBP and BBP (Arning et al., 1996), and the two
nucleotides that affect mBBP(181) binding most stronglywith the branchpoint sequence. We have identified a
yeast protein with sequence specificity for a pre-mRNA also have the strongest effect on BBP(193) binding (Ta-
ble 1). Taken together with the recent characterizationsequence element that ineither system shows sequence
specificity for the branchpoint (UACUAAC) sequence in of BBP and mBBP (Abovich and Rosbash, 1997), the
results suggest that the branchpoint sequence is recog-a remarkable fashion.
Although the specificity of mBBP binding is weaker nized at least twice during spliceosome-complex forma-
tion, first by this protein and then by U2 snRNP.than that of BBP, the results suggest that mBBP is the
80 or 72 kDa protein that cross-links to the branchpoint We do not know which protein regions of BBP contrib-
ute to affinity and specificity. For the pre-mRNA branch-sequence during the early steps of mammalian pre-
mRNA splicing (MacMillan et al., 1994; Chiara et al., point sequence, however, mutations at every position
have a negative effect on BBP(193) binding. Although1996, respectively). Our anti-mBBP antibodies do not
efficiently immunoprecipitate this protein from splicing this correlates well with the poor formation of the CC2
commitment complex and the poor splicing of yeastextracts, which precludes a comparable mammalian
cross-linking experiment (Figure 1). Nonetheless, the substrates that carry these same mutations (Fouser and
Friesen, 1986; Jacquier and Rosbash, 1986; SeÂ raphinproperties of BBP fit with those of the 72 kDa protein, as
it was shown to cross-link to the branchpoint sequence and Rosbash, 1991), it is impossible to distribute the
quantitative effects on splicing to the BBP±branchpointwithin a functional E complex but not in A complexes
(Chiara et al., 1996). Although there are multiple forms interaction, the U2 snRNP±branchpoint interaction, and
to other as yet unidentified branchpoint-interacting fac-of mBBP (Arning et al., 1996), we propose that this pro-
tein(s) and BBP are functional orthologs and recognize tors. We also note that the failure to observe complete
BBP Recognizes the Branchpoint Sequence
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suppression in theoriginal U2 snRNA±UACUAAC pairing
experiments suggested that other factors might be in-
volved in branchpoint recognition (Parker et al., 1987).
Although the yeast protein has been previously char-
acterized in vitro, full-length mBBP has been expressed
and shown to bind RNA almost nonspecifically, with
poly(G) and poly(U) being better than poly(A) and poly(C)
(Arning et al., 1996). Our experiments are consistent with
this report and indicate that mBBP has only modest
branchpoint specificity. Even BBP specificity decreases
in the context of much larger RNA substrates, owing to
the large number of competing nonspecific binding sites
(data not shown). The strategy of using small RNA sub-
strates was therefore important to observe significant
sequence specificity. We suspect that the small-sub-
strate approach is also relevant to the biological context
Figure 6. Model for Branchpoint Recognition in Yeast and Mamma-
of splicing complexes: protein±protein contacts (e.g., lian Pre-mRNA Splicing
Abovich and Rosbash, 1997) might position BBP and See text for details.
restrict binding to a narrow window of pre-mRNA that
includes the branchpoint sequence. In addition, other
pre-mRNA regions might be occupied with different through its modest specificity for a branchpoint se-
RNA-binding proteins and therefore inaccessible. quence (Figure 6). The more degenerate branchpoint
The biological context of splicing complexes is proba- sequences of mammals would then reflect the more
bly also related to the issue of affinity. Neither BBP(193) prominent role of U2AF65 and the more relaxed se-
nor mBBP(181) is a particularly good RNA-binding pro- quence specificity of mBBP. In one study, mutation of
tein. BBP(193) has a KD of 500 nM, and mBBP(181) has the branchpoint sequence did not reveal a contribution
a KD of 30 mM, whereas other RNA-binding proteins have of this sequenceelement toE complexformation (Cham-
KDs of 1 nM or even lower (Daly et al., 1989; Hall and pion-Arnaud et al., 1995). However, this experiment was
Stump, 1992). We cannot rule out the possibility that done with a very strong pyrimidine tract, making it possi-
apparent weak binding is an artifact of a large percent- ble that the strong U2AF65±pyrimidine tract interaction
age of inactive molecules in both protein preparations, masked the contribution of the mBBP±branchpoint se-
although there is no denaturation step in the purification quence interaction.
protocol, and both proteins are chromatographically ho- There is a parallel yeast protein±protein interaction
mogeneous. A more optimistic interpretation is that between Mud2p and BBP, and it would not be surprising
weak binding reflects the interactions of BBP with other were Mud2p to interact with intronic polypyrimidine
splicing factors: they tether BBP (or mBBP) in close tracts (Figure 6). Indeed, Mud2p also cross-links to the
proximity to the branchpoint sequence (Abovich and pre-mRNA site±specifically labeled 3 nt downstream of
Rosbash, 1997), obviating the need for single protein± the branchpoint sequence (data not shown). The fact
high affinity binding. High affinity binding might even be that Mud2p is inessential for viability, as well as for
splicing, fits well with the relatively weak role and con-incompatible with a multistep pathway: a low off-rate
servation of yeast polypyrimidine tracts (Abovich et al.,might be rate limiting and prevent the replacement of
1994). In contrast, the yeast branchpoint is highly con-BBP by U2 snRNP during the assembly pathway (Abo-
served, and BBP is an essential splicing factor. Thevich and Rosbash, 1997; Chiara et al., 1996). These con-
tighter binding and greater sequence specificity of BBPsiderations might be relevant to other in vitro situations
suggest that it makes the larger contribution to branch-where recombinant proteins bind RNA poorly or not at
point selection in the yeast system (Figure 6).all (Lu and Hall, 1995).
If BBP and mBBP are important for branchpoint selec-The protein±RNA interactions suggest that sequence-
tion, it should be possible to swap proteins or proteinspecific RNA binding by both BBP and mBBP contrib-
domains between the two systems. We are currentlyutes to branchpoint recognition and possibly to branch-
testing the prediction that this will lead to more stringentpoint selection during early splicing-complex formation
branchpoint selection in a mammalian system and less(CC2 for yeast and E complex for mammals). mBBP(181)
stringent selection in yeast.binds RNA 50-fold weaker and is less UACUAAC se-
quence±specific than BBP. Although these differences
Experimental Procedurescould be due to the yeast substrate, they more likely
reflect the relative conservation and importance of the Cross-Linking
branchpoint regions in the two systems. In the mamma- UV cross-linking and immunoprecipitations were done as previously
described (Umen and Guthrie, 1995), except that irradiation waslian system, there is evidence that U2AF65, through its
carried out in a stratalinker with 256 nm bulbs for 14 min. RNA sub-strong interaction with the polypyrimidine tract (Zamore
strates: plasmids D2±3 (wild type) and a 7 bp deletion (DUACUAAC)and Green, 1991), makes a major contribution to branch-
(SeÂ raphin and Rosbash, 1991) were used as templates for in vitro
point selection. Taken together, the data suggest that transcription with T7 RNA Polymerase. [a-32P]ATP and -UTP were
mBBP is positioned primarily through its strong protein± included in the reactions to generate the uniformly labeled sub-
strates. For the site specific±labeled pre-mRNA, the D2±3 plasmidprotein interaction with U2AF65 and only secondarily
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was used to generate templates by PCR for in vitro transcription. L. A. Monaghan for excellent secretarial assistance. This work was
supported by a grant from the NIH (GM-23549) to M. R.Oligonucleotide primers for the 59 half molecule were a 17-mer con-
taining the T7 promoter and 59-TTGTTAGTATACTGA TAT-39. Oligo-
nucleotide primers for the 39 half molecule were 59-GACTAAT
Received March 31, 1997; revised April 23, 1997.ACGACTCACTATAGGTGAATTGCATTTACAAACTTT-39 and 59-CCT
TAGAAGCACGCTTGACGG-39. Transcription, labeling of the 39 half
RNA with [g-32P]ATP,and ligation were done as previously described
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